STERIS reported Q4 adjusted EPS of $2.83 and revenue of $1.59 billion, both slight misses versus expectations, even as the company posted broad growth across the business. The stock dipped after hours on the earnings miss, though FY27 guidance suggests underlying fundamentals remain intact.
STERIS reported Q4 adjusted EPS of $2.83 and revenue of $1.59 billion, both slight misses versus expectations, even as the company posted broad growth across the business. The stock dipped after hours on the earnings miss, though FY27 guidance suggests underlying fundamentals remain intact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
